Test Vedio

Play Video
Recce’s New Class of Synthetic Anti-Infectives have a universal mechanism of action with the ability to overcome hyper-cellular mutation of bacteria and viruses. Recce’s anti-infectives are unique – their potency does not diminish even with repeated use, a common failure associated with existing drugs.
Recce continues to strengthen and expand its product pipeline of therapeutic options for ‘difficult to treat’ bacterial and viral infections – including their mutated forms.